Physician

Andrew Ng, M.D.

According to 2025 Medicare claims, Andrew Ng, M.D. (NPI: 1962667188) practices pain management in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is JEFFERSON UNIVERSITY PHYSICIANS (NPI: 1326093675; TIN: 232809585) and primary practice location at 19112-1016. Ng is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Ng's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 364 traditional Medicare patients, billed 1,537 HCPCS/CPT codes, and received $102,233 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 5,055 prescription claims across 548 beneficiaries totaling $268,593 in drug costs, led by Xtampza Er (Oxycodone Myristate). Open Payments data shows 3 records totaling $156. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	251	937	$59,485
2016	299	1,225	$73,941
2017	297	1,298	$78,254
2018	310	1,317	$78,706
2019	289	1,115	$65,775
2020	289	898	$46,459
2021	326	1,149	$73,425
2022	317	1,082	$64,192
2023	349	1,239	$91,644
2024	364	1,537	$102,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	258	2,432	$210,021
2016	313	3,141	$306,800
2017	339	3,746	$407,035
2018	326	3,869	$425,087
2019	349	3,577	$356,442
2020	384	3,759	$286,636
2021	444	4,174	$312,453
2022	461	4,589	$278,490
2023	537	4,863	$292,269
2024	548	5,055	$268,593

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	110	151	$104
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	96	96	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	244	503	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	141	204	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	79	99	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	68	2,021	$48,597
Percocet	Oxycodone Hcl/Acetaminophen	12	359	$47,208
Oxycodone Hcl	Oxycodone Hcl	1,169	30,876	$23,595
Nucynta Er	Tapentadol Hcl	13	390	$16,280
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	699	18,773	$12,996

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$156	Averitas Pharma Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Ng, M.D.?

Tedicare shows public-source Medicare data for Andrew Ng, M.D. (NPI 1962667188), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Ng, M.D. have ACO affiliation data?

Andrew Ng, M.D. is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Andrew Ng, M.D.?

Andrew Ng, M.D. is linked to JEFFERSON UNIVERSITY PHYSICIANS (billing NPI 1326093675) in the available physician profile data.

Does Andrew Ng, M.D. have Open Payments data?

Andrew Ng, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.